USANA Health Sciences, Inc.
USNA
$29.39
-$0.63-2.10%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.15% | -73.43% | -6.52% | -39.67% | -10.04% |
| Total Depreciation and Amortization | 101.51% | 20.80% | 7.75% | 10.91% | -2.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.40% | -79.41% | -3.07% | 21.68% | -20.04% |
| Change in Net Operating Assets | 17.35% | -2,423.39% | 970.24% | 44.95% | 43.17% |
| Cash from Operations | -12.45% | -77.77% | 32.83% | -16.34% | 37.79% |
| Capital Expenditure | 12.43% | 75.40% | -64.99% | 25.99% | -51.92% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.22% | -- | -- | -70.20% | 31.55% |
| Cash from Investing | 4.74% | -2,701.67% | -60.80% | -963.69% | -20.43% |
| Total Debt Issued | -- | 2,803.79% | -- | -79.47% | -- |
| Total Debt Repaid | -- | -- | -- | -96.80% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -15.89% | 44.78% | 99.32% | 43.64% | -336.32% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -21.10% | 3,384.80% | 99.33% | -2,360.00% | -273.43% |
| Foreign Exchange rate Adjustments | 118.88% | -267.57% | 341.38% | 79.96% | -582.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.05% | -882.28% | 373.21% | -11.06% | -130.37% |